Skip to main content
Featured News MS in Health-System Pharmacy News Sidebar Featured News,
Brittany Jennings
February 3, 2021



UNC Eshelman School of Pharmacy Master’s student Charlie Summerlin, Pharm.D., BCPS, is a 2020 recipient of the Board of Pharmacy Specialties (BPS) PGY-2 Residency Research Seed Grants.

Now in its third year, this program awards up to two $5,000 seed grants to PGY-2 pharmacy residents who design projects to evaluate the impact of pharmacist board certification on medication-related outcomes for patients, demonstrate the value of board certification for pharmacist specialists to key stakeholder groups, or contribute to credentialing or privileging of pharmacist specialists across practice settings.

Summerlin, along with Assistant Director of Acute and Ambulatory Clinical Services at UNC Hospitals Kayla Waldron, Pharm.D., M.S., BCPS, created a proposal titled: “Development and Implementation of a Standardized Process for Identifying Clinical Outcomes Measures Impacted by Board-Certified Clinic-Based Pharmacists (CBPs).”

In their proposal, Summerlin and Waldron wrote: “Minimal guidance is available on the process for identification and selection of appropriate clinical outcomes measures to associate with the work of board-certified clinical pharmacists despite an increased need to demonstrate value and impact…

While various medication-related outcomes measures exist, a significant gap remains within pharmacy practice, particularly for specialty disease states… In this mixed-methods project, we will seek input from a multidisciplinary stakeholder group through the modified Delphi method to identify specific outcomes measures to track for board-certified CBPs in four pilot specialty clinics. With stakeholder focus groups and rapid improvements via the Plan-Do-Study-Act (PDSA) framework, we will also develop and refine a standardized, reproducible process for identifying outcomes measures that demonstrate the impact and value of board-certified CBPs.”

BPS Board Chair, Karen Gunning, Pharm.D., BCPS, BCACP, said, “It is wonderful to see a growing number of outstanding applications for funding consideration and the growing number of resulting publications. The BPS seed grants help create unique opportunities for PGY-2 specialty residents to contribute to research about the value of BPS board certification.”

The BPS was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally.

 

Latest News


Comments are closed.